Results 131 to 140 of about 2,311,673 (316)

Stroke and migraine is there a possible comorbidity? [PDF]

, 2016
The association between migraine and stroke is still a dilemma for neurologists. Migraine is associated with an increased stroke risk and it is considered an independent risk factor for ischaemic stroke in a particular subgroup of patients.
Del Balzo, Francesca, Duse, Marzia, Nicita, Francesco, Occasi, Francesca, Papetti, Laura, Properzi, Enrico, Spalice, Alberto, Zicari, Anna Maria   +7 more
core   +2 more sources

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis? [PDF]

, 2019
Porto sinusoidal vascular liver disease (PSVD) and portal vein thrombosis (PVT) are distinct vascular liver diseases characterized, respectively, by an intrahepatic and a prehepatic obstacle to the flow in the liver portal system. PVT may also occur as a
D'Amati, G., Gioia, S., Nardelli, S., Ridola, L., Riggio, O.   +4 more
core   +1 more source

Smartphone cognitive behavioral therapy for prevention of depressive symptoms in patients with recurrent pregnancy loss: an exploratory decentralized, parallel‐group, multicenter, open, individually randomized, fully factorial trial

Psychiatry and Clinical Neurosciences, EarlyView.
Aim The aim was to explore the preventive effects of smartphone cognitive behavioral therapy (CBT) in addressing depression and anxiety in patients with recurrent pregnancy loss (RPL) due to lack of such previous studies. Methods This was an exploratory decentralized, parallel‐group, multicenter, open, individually randomized, fully factorial trial.
Sakura Ogasawara, Minami Ashio, Yoshitaka Yano, Ayano Otani, Chihiro Banno, Shinobu Goto, Tamao Kitaori, Hiroyuki Yoshihara, Koji Aoki, Hisashi Noma, Toshi A. Furukawa, Mayumi Sugiura‐Ogasawara   +11 more
wiley   +1 more source

Detection of anti-cardiolipin and anti-β2glycoprotein I antibodies differs between platforms without influence on association with clinical symptoms [PDF]

, 2019
Background: The anti-phospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity with persistent presence of anti-phospholipid antibodies (aPL).
Chayoua, Walid, de Laat, Bas, Devreese, Katrien, Fontana, Pierre, Gianniello, Francesca, Gris, Jean-Christophe, Kelchtermans, Hilde, Moore, Gary W, Musial, Jacek, Remijn, Jasper, Urbanus, Rolf T, Wahl, Denis, Zuily, Stéphane   +12 more
core   +4 more sources

McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome

Journal of Thrombosis and Haemostasis, 2018
The McMaster RARE‐Bestpractices project group selected the catastrophic antiphospholipid syndrome (CAPS) for a pilot exercise in guideline development for a rare disease.
K. Legault, H. Schünemann, C. Hillis, C. Yeung, E. Akl, E. Akl, M. Carrier, R. Cervera, M. Crowther, F. Dentali, D. Erkan, G. Espinosa, M. Khamashta, Joerg J. Meerpohl, K. Moffat, S. O’Brien, V. Pengo, J. Rand, I. R. Pintó, L. Thom, Alfonso Iorio   +20 more
semanticscholar   +1 more source

Hughes syndrome antiphospholipid syndrome

Hamdan Medical Journal, 2008
An increasingly important link between aPL antibodies and a clinical syndrome is becoming recognized worldwide. This syndrome, known as the antiphospholipid syndrome (APS) or Hughes syndrome, is a prothrombotic disorder leading to both arterial and venous thrombosis and, in pregnancy, recurrent abortion and pregnancy loss (Figure 13.1).
openaire   +2 more sources

Obstetric antiphospholipid syndrome

Autoimmunity Reviews, 2012
Antiphospholipid syndrome (APS) in pregnancy has a serious impact on maternal and fetal morbidity. It causes recurrent pregnancy miscarriage and it is associated with other adverse obstetric findings like preterm delivery, intrauterine growth restriction, preeclampsia, HELLP syndrome and others.
Galarza-Maldonado, Claudio, Kourilovitch, Maria R., Pérez-Fernández, Oscar M., Gaybor, Mariana, Cordero, Christian, Cabrera, Sonia, Soroka, Nikolai F.   +6 more
openaire   +3 more sources

Huntington's Disease‐like Syndrome as a Rare Presentation of CACNA1A‐Related Disorder

Movement Disorders Clinical Practice, EarlyView.
Petros Boumis, Constantin Potagas, Christos Koros, Vasilios Constantinides, Nikolaos Ragazos, Chrysoula Koniari, Stavroula Aristeidou, Chrisoula Kartanou, Emmanouela Linardaki, Nektarios Tavernarakis, Evangelos Anagnostou, Leonidas Stefanis, Socratis Papageorgiou, Georgia Karadima, Georgios Koutsis   +14 more
wiley   +1 more source

Proton Pump Inhibitor‐Induced Fundic Gland Polyps With Massive Bleeding Regressed on Alternative Histamine 2 Receptor Antagonist Therapy

DEN Open, Volume 6, Issue 1, April 2026.
Abstract We report a case of massive bleeding from proton pump inhibitor (PPI)‐induced fundic gland polyps (FGPs) that regressed after switching to a histamine‐2 receptor antagonist (H2RA). A 46‐year‐old man with antiphospholipid syndrome had been receiving warfarin and lansoprazole for 4 years.
Ryosuke Ikeda, Hiroaki Kaneko, Hiroki Sato, Yuto Matsuoka, Tomomi Hamaguchi, Aya Ikeda, Yoshihiro Goda, Soichiro Sue, Kuniyasu Irie, Shin Maeda   +9 more
wiley   +1 more source